Do analysts rate NEPH or RVP?

Nephros presently has a consensus price target of $4.00, suggesting a potential upside of 13.64%. Given Nephros' stronger consensus rating and higher possible upside, research analysts plainly believe Nephros is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nephros 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend RMTI or RVP?

Rockwell Medical currently has a consensus target price of $20.00, suggesting a potential upside of 161.10%. Given Rockwell Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend RVP or CUPR?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Cuprina Holdings (Cayman) 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, RVP or CUPR?

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Retractable Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Retractable Technologies $33.90M 0.52 -$7.01M -$0.12 N/A Cuprina Holdings (Cayman) $40K 348.25 -$3.63M N/A N/A

Do analysts rate RVP or LUCY?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Do analysts prefer RVP or BMRA?

Biomerica has a consensus price target of $9.00, suggesting a potential upside of 397.24%. Given Biomerica's stronger consensus rating and higher possible upside, analysts clearly believe Biomerica is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Biomerica 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Retractable Technologies (RVP) Competitors

$0.59 -0.02 (-3.11%)

As of 10/14/2026 04:00 PM Eastern

Compare

RVP vs. NEPH, RMTI, CUPR, LUCY, and BMRA

Should you buy Retractable Technologies stock or one of its competitors? Retractable Technologies's main competitors and comparable companies include Nephros (NEPH), Rockwell Medical (RMTI), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCY), and Biomerica (BMRA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Retractable Technologies compare to Nephros?

Nephros (NASDAQ:NEPH) and Retractable Technologies (NYSE:RVP) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, media sentiment, institutional ownership, earnings and risk.

In the previous week, Nephros had 3 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Nephros and 0 mentions for Retractable Technologies. Nephros' average media sentiment score of 0.70 beat Retractable Technologies' score of 0.00 indicating that Nephros is being referred to more favorably in the media.

Company	Overall Sentiment
Nephros	Positive
Retractable Technologies	Neutral

Nephros has a net margin of 8.38% compared to Retractable Technologies' net margin of -41.11%. Nephros' return on equity of 10.60% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nephros	8.38%	10.60%	8.05%
Retractable Technologies	-41.11%	-17.15%	-9.33%

41.1% of Nephros shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 6.7% of Nephros shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Nephros presently has a consensus price target of $4.00, suggesting a potential upside of 13.64%. Given Nephros' stronger consensus rating and higher possible upside, research analysts plainly believe Nephros is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nephros	0 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.25
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Nephros has higher earnings, but lower revenue than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Nephros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nephros	$18.79M	2.03	$1.19M	$0.16	22.00
Retractable Technologies	$33.90M	0.52	-$7.01M	-$0.12	N/A

Nephros has a beta of 1.64, indicating that its share price is 64% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market.

Summary

Nephros beats Retractable Technologies on 14 of the 16 factors compared between the two stocks.

How does Retractable Technologies compare to Rockwell Medical?

Rockwell Medical (NASDAQ:RMTI) and Retractable Technologies (NYSE:RVP) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, institutional ownership and media sentiment.

Rockwell Medical has a beta of 1.63, suggesting that its stock price is 63% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market.

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by company insiders. Comparatively, 59.5% of Retractable Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Rockwell Medical currently has a consensus target price of $20.00, suggesting a potential upside of 161.10%. Given Rockwell Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

In the previous week, Rockwell Medical had 3 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Rockwell Medical and 0 mentions for Retractable Technologies. Rockwell Medical's average media sentiment score of 0.40 beat Retractable Technologies' score of 0.00 indicating that Rockwell Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Rockwell Medical	Neutral
Retractable Technologies	Neutral

Rockwell Medical has a net margin of -7.33% compared to Retractable Technologies' net margin of -41.11%. Rockwell Medical's return on equity of -14.03% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.33%	-14.03%	-8.90%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Rockwell Medical has higher revenue and earnings than Retractable Technologies. Rockwell Medical is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.45	-$5.31M	-$1.34	N/A
Retractable Technologies	$33.90M	0.52	-$7.01M	-$0.12	N/A

Summary

Rockwell Medical beats Retractable Technologies on 12 of the 15 factors compared between the two stocks.

How does Retractable Technologies compare to Cuprina Holdings (Cayman)?

Retractable Technologies (NYSE:RVP) and Cuprina Holdings (Cayman) (NASDAQ:CUPR) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability, risk and media sentiment.

In the previous week, Cuprina Holdings (Cayman) had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for Cuprina Holdings (Cayman) and 0 mentions for Retractable Technologies. Cuprina Holdings (Cayman)'s average media sentiment score of 1.79 beat Retractable Technologies' score of 0.00 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Cuprina Holdings (Cayman)	Very Positive

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to Retractable Technologies' net margin of -41.11%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Cuprina Holdings (Cayman)	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Cuprina Holdings (Cayman)	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cuprina Holdings (Cayman) has lower revenue, but higher earnings than Retractable Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.52	-$7.01M	-$0.12	N/A
Cuprina Holdings (Cayman)	$40K	348.25	-$3.63M	N/A	N/A

Retractable Technologies has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market. Comparatively, Cuprina Holdings (Cayman) has a beta of -0.1, indicating that its share price is 110% less volatile than the broader market.

7.6% of Retractable Technologies shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Cuprina Holdings (Cayman) beats Retractable Technologies on 8 of the 12 factors compared between the two stocks.

How does Retractable Technologies compare to Innovative Eyewear?

Retractable Technologies (NYSE:RVP) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, valuation, dividends, profitability, institutional ownership, media sentiment, earnings and analyst recommendations.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Retractable Technologies has a beta of 1.2, meaning that its share price is 20% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.74, meaning that its share price is 174% more volatile than the broader market.

In the previous week, Innovative Eyewear had 3 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Innovative Eyewear and 0 mentions for Retractable Technologies. Innovative Eyewear's average media sentiment score of 0.50 beat Retractable Technologies' score of 0.00 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Innovative Eyewear	Positive

7.6% of Retractable Technologies shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 59.5% of Retractable Technologies shares are owned by company insiders. Comparatively, 1.8% of Innovative Eyewear shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Retractable Technologies has higher revenue and earnings than Innovative Eyewear. Retractable Technologies is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.52	-$7.01M	-$0.12	N/A
Innovative Eyewear	$2.66M	2.73	-$7.59M	-$1.29	N/A

Retractable Technologies has a net margin of -41.11% compared to Innovative Eyewear's net margin of -225.26%. Retractable Technologies' return on equity of -17.15% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Innovative Eyewear	-225.26%	-88.90%	-80.34%

Summary

Retractable Technologies beats Innovative Eyewear on 8 of the 13 factors compared between the two stocks.

How does Retractable Technologies compare to Biomerica?

Retractable Technologies (NYSE:RVP) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

In the previous week, Biomerica had 3 more articles in the media than Retractable Technologies. MarketBeat recorded 3 mentions for Biomerica and 0 mentions for Retractable Technologies. Biomerica's average media sentiment score of 0.84 beat Retractable Technologies' score of 0.00 indicating that Biomerica is being referred to more favorably in the news media.

Company	Overall Sentiment
Retractable Technologies	Neutral
Biomerica	Positive

Retractable Technologies has a net margin of -41.11% compared to Biomerica's net margin of -84.79%. Retractable Technologies' return on equity of -17.15% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Retractable Technologies	-41.11%	-17.15%	-9.33%
Biomerica	-84.79%	-97.19%	-61.57%

Biomerica has lower revenue, but higher earnings than Retractable Technologies. Retractable Technologies is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Retractable Technologies	$33.90M	0.52	-$7.01M	-$0.12	N/A
Biomerica	$4.45M	1.26	-$3.78M	-$1.27	N/A

Biomerica has a consensus price target of $9.00, suggesting a potential upside of 397.24%. Given Biomerica's stronger consensus rating and higher possible upside, analysts clearly believe Biomerica is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

7.6% of Retractable Technologies shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 59.5% of Retractable Technologies shares are held by insiders. Comparatively, 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Retractable Technologies has a beta of 1.2, indicating that its share price is 20% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market.

Summary

Retractable Technologies beats Biomerica on 8 of the 15 factors compared between the two stocks.

Get Retractable Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RVP vs. The Competition

Export

Metric	Retractable Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$18.26M	$5.59B	$7.19B	$23.07B
Dividend Yield	N/A	1.74%	2.52%	3.70%
P/E Ratio	-1.10	21.32	223.62	24.82
Price / Sales	0.52	65.09	547.34	21.35
Price / Cash	48.25	32.11	76.68	36.37
Price / Book	0.18	5.72	10.22	4.66
Net Income	-$7.01M	$146.93M	$3.50B	$1.07B
7 Day Performance	-10.41%	-1.61%	-3.50%	-1.40%
1 Month Performance	-12.78%	-4.38%	-7.78%	-3.92%
1 Year Performance	-39.36%	0.69%	0.79%	4.77%

Retractable Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RVP Retractable Technologies	N/A	$0.59 -2.8%	N/A	-35.3%	$18.26M	$33.90M	N/A	201
NEPH Nephros	3.9933 of 5 stars	$3.20 +6.0%	$4.00 +25.0%	-34.6%	$32.80M	$18.79M	20.00	36	News Coverage Short Interest Decrease
RMTI Rockwell Medical	3.3647 of 5 stars	$8.22 +7.5%	$20.00 +143.3%	-36.2%	$30.83M	$69.26M	N/A	157	News Coverage High Trading Volume
CUPR Cuprina Holdings (Cayman)	0.8873 of 5 stars	$1.99 -8.3%	N/A	N/A	$15.20M	$40K	N/A	10	Positive News Analyst Downgrade Gap Down
LUCY Innovative Eyewear	0.5262 of 5 stars	$0.91 -1.4%	N/A	-56.0%	$8.06M	$2.66M	N/A	13

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:RVP) was last updated on 10/15/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Retractable Technologies (RVP) Competitors

RVP vs. NEPH, RMTI, CUPR, LUCY, and BMRA

How does Retractable Technologies compare to Nephros?

Summary

How does Retractable Technologies compare to Rockwell Medical?

Summary

How does Retractable Technologies compare to Cuprina Holdings (Cayman)?

Summary

How does Retractable Technologies compare to Innovative Eyewear?

Summary

How does Retractable Technologies compare to Biomerica?

Summary

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Retractable Technologies (RVP) Competitors

RVP vs. NEPH, RMTI, CUPR, LUCY, and BMRA

How does Retractable Technologies compare to Nephros?

Does the media refer more to NEPH or RVP?

Is NEPH or RVP more profitable?

Do institutionals and insiders hold more shares of NEPH or RVP?

Do analysts rate NEPH or RVP?

Which has better earnings & valuation, NEPH or RVP?

Which has more volatility & risk, NEPH or RVP?

Summary

How does Retractable Technologies compare to Rockwell Medical?

Which has more volatility & risk, RMTI or RVP?

Do insiders and institutionals hold more shares of RMTI or RVP?

Do analysts recommend RMTI or RVP?

Does the media favor RMTI or RVP?

Is RMTI or RVP more profitable?

Which has better valuation and earnings, RMTI or RVP?

Summary

How does Retractable Technologies compare to Cuprina Holdings (Cayman)?

Does the media prefer RVP or CUPR?

Is RVP or CUPR more profitable?

Do analysts recommend RVP or CUPR?

Which has stronger valuation & earnings, RVP or CUPR?

Which has more risk and volatility, RVP or CUPR?

Do institutionals & insiders believe in RVP or CUPR?

Summary

How does Retractable Technologies compare to Innovative Eyewear?

Do analysts rate RVP or LUCY?

Which has more volatility & risk, RVP or LUCY?

Does the media favor RVP or LUCY?

Do institutionals and insiders believe in RVP or LUCY?

Which has higher earnings & valuation, RVP or LUCY?

Is RVP or LUCY more profitable?

Summary

How does Retractable Technologies compare to Biomerica?

Does the media favor RVP or BMRA?

Is RVP or BMRA more profitable?

Which has higher valuation & earnings, RVP or BMRA?

Do analysts prefer RVP or BMRA?

Do institutionals & insiders have more ownership in RVP or BMRA?

Which has more volatility & risk, RVP or BMRA?

Summary

Media Sentiment Over Time

RVP vs. The Competition

Retractable Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools